Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 20:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- SGD 6.54T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | SGD 6.2B | SGD 17.65 | 1.44% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | SGD 12.4B | SGD 130.05 | 7.50% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | SGD 8.4B | SGD 123.74 | 0.38% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | SGD 6.8B | SGD 160.77 | 0.77% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | SGD 5.1B | SGD 37.35 | 1.41% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | SGD 9.6B | SGD 122.64 | 0.01% down | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | SGD 6.2B | SGD 110.00 | 1.93% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | SGD 12.9B | SGD 85.29 | 5.47% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | SGD 30.2B | SGD 26.32 | 0.20% down | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | SGD 36.1B | SGD 49.88 | 0.08% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | SGD 5.9B | SGD 53.59 | 1.15% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | SGD 9.8B | SGD 28.20 | 3.55% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | SGD 51.1B | SGD 88.93 | 0.41% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | SGD 63.4B | SGD 54.31 | 1.18% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | SGD 40.7B | SGD 66.04 | 1.44% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | SGD 11.1B | SGD 396.65 | 0.83% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | SGD 10.1B | SGD 60.07 | 2.49% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | SGD 87.7B | SGD 27.45 | 1.64% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | SGD 439.9B | SGD 178.42 | 3.49% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | SGD 10.7B | SGD 163.42 | 1.65% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | SGD 6.2B | SGD 65.10 | 1.21% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | SGD 7.7B | SGD 385.17 | 1.66% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | SGD 850.1B | SGD 353.13 | 1.75% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | SGD 20.4B | SGD 317.52 | 2.29% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | SGD 126.4B | SGD 1,221.75 | 1.08% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | SGD 1.59T | SGD 1,789.86 | 1.95% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | SGD 158.1B | SGD 77.32 | 2.27% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | SGD 8.2B | SGD 201.46 | 0.95% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | SGD 7.8B | SGD 118.85 | 0.23% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | SGD 22.9B | SGD 349.47 | 0.07% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | SGD 176.3B | SGD 695.28 | 0.93% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | SGD 653.5B | SGD 369.71 | 2.09% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | SGD 378.3B | SGD 200.30 | 2.39% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | SGD 31.9B | SGD 747.88 | 0.71% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | SGD 17.3B | SGD 34.68 | 4.04% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | SGD 19.6B | SGD 100.41 | 1.38% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | SGD 59.5B | SGD 521.16 | 2.21% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | SGD 206.8B | SGD 36.28 | 1.18% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | SGD 10.6B | SGD 153.26 | 1.92% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | SGD 15.3B | SGD 79.19 | 4.95% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | SGD 7.9B | SGD 55.89 | 0.81% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | SGD 126B | SGD 62.85 | 1.02% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | SGD 16.1B | SGD 19.36 | 1.52% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | SGD 358.2B | SGD 230.99 | 1.73% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | SGD 7.4B | SGD 10.90 | 2.03% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | SGD 146.1B | SGD 60.85 | 0.72% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | SGD 9.1B | SGD 172.76 | 1.46% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | SGD 9.6B | SGD 87.80 | 2.83% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | SGD 224.3B | SGD 50.89 | 3.03% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | SGD 234.5B | SGD 135.42 | 0.29% up | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | SGD 6.5B | SGD 77.57 | 0.34% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | SGD 9.3B | SGD 66.53 | 0.11% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | SGD 6.3B | SGD 36.25 | 0.93% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | SGD 11.9B | SGD 510.98 | 6.10% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | SGD 9.4B | SGD 107.76 | 1.78% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | SGD 45.3B | SGD 111.60 | 3.67% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | SGD 10.8B | SGD 13.55 | 1.50% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | SGD 33.9B | SGD 154.58 | 1.63% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | SGD 4.1B | SGD 20.94 | 0.81% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | SGD 6B | SGD 35.90 | 3.26% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | SGD 25.9B | SGD 193.21 | 4.27% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2896 SGD).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 20:27 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of SGD 6.54T as of 18 Nov 2026, 20:27 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.